2023 Annual Meeting | C24 - Pediatric Headache

Date Saturday 04/22/23

Time 02:45 PM - 04:45 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Kenneth J. Mack, MD, PhD, FAAN

Topic(s) Child Neurology and Developmental Neurology, Headache

Learning Objectives Participants should be able to apply a holistic approach to the treatment of children and adolescents with migraine that ranges from lifestyle factors, to appropriate acute therapies, to prevention; appraise recent studies of injection and neurostimulation therapies in child and adolescent migraine; and recognize the frequent co-morbidities in migraine, and understand how these co-morbid factors contribute to our patient's disease burden.

CME Available 2.00 CME credits

Core Competencies Medical Knowledge, Practice-based Learning and Improvement, Quality Improvement

Program Level Intermediate

Program Tracks Advanced Practice Provider

Recommended Audience Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider

Teaching Styles Didactic

Event Timeline
02:45 PM - 02:45 PM EST	Speaker	Introduction Kenneth J. Mack, MD, PhD, FAAN
02:45 PM - 03:25 PM EST	Speaker	Evaluation and Treatment of Pediatric Migraine Hannah Shapiro, MD
03:25 PM - 04:05 PM EST	Speaker	Blocks, Botox, and Buzzers for Pediatric Headache Christina L. Szperka, MD
04:05 PM - 04:45 PM EST	Speaker	Chronification and Co-Morbidities in Pediatric Headache Kenneth J. Mack, MD, PhD, FAAN

Faculty Disclosures
Kenneth J. Mack, MD, PhD, FAAN	Dr. Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbieVie. Dr. Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Upsher Smith. Dr. Mack has received publishing royalties from a publication relating to health care.
Christina L. Szperka, MD	The institution of Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Upsher Smith. The institution of Dr. Szperka has received research support from NINDS. The institution of Dr. Szperka has received research support from PCORI. The institution of Dr. Szperka has received research support from International Headache Society.
Hannah Shapiro, MD	Dr. Shapiro has nothing to disclose.

��ɫ��

��ɫ��